Aug 04
William McGivney, PhD: It is interesting to see "record profits" for managed care companies in the face of the Covi… https://t.co/rT8cnBEEZu

Jul 27
Dean Gesme, MD: Trump gave just Congress and manufacturers 30 days to develop and pass a Part B Medicare drug acqui… https://t.co/pK6VjPFbo0

Jul 24
A panel of three breast cancer experts looked at some of the big studies at #ASCO20 and discussed treatment advance… https://t.co/ZcPRjbtKvL

Jul 24
OBR spoke at length with ASCO's president, Dr. Howard "Skip" Burris, about the pros and cons of #ASCO20's virtual f… https://t.co/9Bq8oJfj5c

Jul 23
A lack of interoperability in the nation's healthcare system has detracted from patient care, leading to poor healt… https://t.co/t6o30WgMjU

Jul 20
William McGivney, PhD: It is with fondness and a smile that I read the story about the distress thermometer now bei… https://t.co/oWDatBpFnu

Jul 15
H. Jack West, MD: Unclear to me why this doesn't raise alarm bells as a conflict of interest. Why is an institution… https://t.co/7pAHP6YnWx

Jul 09
H. Jack West, MD: The benefit of low dose chest CT screening for lung cancer remains somewhat controversial, but th… https://t.co/8wOgsSCY7q

Jul 08
Howard S. Hochster, MD: While a "complete response" is great for our patients, the Complete Response Letter was les… https://t.co/yQGkfvpMCF

Jul 02
A panel of three breast cancer experts looked at some of the big studies at #ASCO20 and discussed treatment advance… https://t.co/ve0XD0cWDY